{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:25:06Z","timestamp":1754486706162,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s40291-024-00697-y","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T12:02:22Z","timestamp":1707307342000},"page":"215-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chimeric Genes Causing 11\u03b2-Hydroxylase Deficiency: Implications in Clinical and Molecular Diagnosis"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3472-8898","authenticated-orcid":false,"given":"Paola","family":"Concolino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"key":"697_CR1","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1210\/jc.2009-2631","volume":"95","author":"PW Speiser","year":"2010","unstructured":"Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Endocrine Society. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:4133\u201360. https:\/\/doi.org\/10.1210\/jc.2009-2631.","journal-title":"J Clin Endocrinol Metab."},{"key":"697_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12020-011-9591-x","volume":"41","author":"H Falhammar","year":"2012","unstructured":"Falhammar H, Thoren M. Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine. 2012;41:355\u201373. https:\/\/doi.org\/10.1007\/s12020-011-9591-x.","journal-title":"Endocrine"},{"key":"697_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12020-016-1189-x","volume":"55","author":"K Bulsari","year":"2017","unstructured":"Bulsari K, Falhammar H. Clinical perspectives in congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency. Endocrine. 2017;55:19\u201336. https:\/\/doi.org\/10.1007\/s12020-016-1189-x.","journal-title":"Endocrine"},{"key":"697_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1210\/edrv.21.3.0398","volume":"21","author":"PC White","year":"2000","unstructured":"White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21:245\u201391. https:\/\/doi.org\/10.1210\/edrv.21.3.0398.","journal-title":"Endocr Rev"},{"key":"697_CR5","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(05)66736-0","volume":"365","author":"DP Merke","year":"2005","unstructured":"Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005;365:2125\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(05)66736-0.","journal-title":"Lancet"},{"key":"697_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1210\/jcem-56-2-222","volume":"56","author":"M Zachmann","year":"1983","unstructured":"Zachmann M, Tassinari D, Prader A. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients. J Clin Endocrinol Metab. 1983;56:222\u20139. https:\/\/doi.org\/10.1210\/jcem-56-2-222.","journal-title":"J Clin Endocrinol Metab"},{"key":"697_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.tem.2008.01.002","volume":"19","author":"S Nimkarn","year":"2008","unstructured":"Nimkarn S, New MI. Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia. Trends Endocrinol Metab. 2008;19:96\u20139. https:\/\/doi.org\/10.1016\/j.tem.2008.01.002.","journal-title":"Trends Endocrinol Metab"},{"key":"697_CR8","doi-asserted-by":"publisher","first-page":"20961","DOI":"10.1016\/S0021-9258(19)30030-4","volume":"264","author":"E Mornet","year":"1989","unstructured":"Mornet E, Dupont J, Vitek A, White PC. Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). J Biol Chem. 1989;264:20961\u20137.","journal-title":"J Biol Chem"},{"key":"697_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1210\/jcem-30-3-361","volume":"30","author":"MI New","year":"1970","unstructured":"New MI, Seaman MP. Secretion rates of cortisol and aldosterone precursors in various forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1970;30:361\u201371. https:\/\/doi.org\/10.1210\/jcem-30-3-361.","journal-title":"J Clin Endocrinol Metab"},{"key":"697_CR10","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1210\/jcem.86.3.7326","volume":"86","author":"KM Kayes-Wandover","year":"2001","unstructured":"Kayes-Wandover KM, Schindler RE, Taylor HC, White PC. Type 1 aldosterone synthase deficiency presenting in a middle-aged man. J Clin Endocrinol Metab. 2001;86:1008\u201312. https:\/\/doi.org\/10.1210\/jcem.86.3.7326.","journal-title":"J Clin Endocrinol Metab"},{"key":"697_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2019.108448","volume":"150","author":"H Miao","year":"2019","unstructured":"Miao H, Yu Z, Lu L, Zhu H, Auchus RJ, Liu J, et al. Analysis of novel heterozygous mutations in the CYP11B2 gene causing congenital aldosterone synthase deficiency and literature review. Steroids. 2019;150: 108448. https:\/\/doi.org\/10.1016\/j.steroids.2019.108448.","journal-title":"Steroids"},{"key":"697_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000281417","volume":"74","author":"L Chabraoui","year":"2010","unstructured":"Chabraoui L, Abid F, Menassa R, Gaouzi A, El Hessni A, Morel Y. Three novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency in a Moroccan population. Horm Res Paediatr. 2010;74:182\u20139. https:\/\/doi.org\/10.1159\/000281417.","journal-title":"Horm Res Paediatr"},{"key":"697_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/ajmg.1320420617","volume":"42","author":"A R\u00f6sler","year":"1992","unstructured":"R\u00f6sler A, Leiberman E, Cohen T. High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco. Am J Med Genet. 1992;42:827\u201334. https:\/\/doi.org\/10.1002\/ajmg.1320420617.","journal-title":"Am J Med Genet"},{"issue":"61\u201379","key":"697_CR14","doi-asserted-by":"publisher","first-page":"vi","DOI":"10.1016\/s0889-8529(08)70019-7","volume":"30","author":"PC White","year":"2001","unstructured":"White PC. Steroid 11 beta-hydroxylase deficiency and related disorders. Endocrinol Metab Clin N Am. 2001;30(61\u201379):vi. https:\/\/doi.org\/10.1016\/s0889-8529(08)70019-7.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"697_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jsbmb.2016.03.006","volume":"165","author":"N Kandemir","year":"2017","unstructured":"Kandemir N, Yilmaz DY, Gonc EN, Ozon A, Alikasifoglu A, Dursun A, et al. Novel and prevalent CYP11B1 gene mutations in Turkish patients with 11-\u03b2 hydroxylase deficiency. J Steroid Biochem Mol Biol. 2017;165:57\u201363. https:\/\/doi.org\/10.1016\/j.jsbmb.2016.03.006.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"697_CR16","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1073\/pnas.90.10.4552","volume":"90","author":"KM Curnow","year":"1993","unstructured":"Curnow KM, Slutsker L, Vitek J, Cole T, Speiser PW, New MI, et al. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci USA. 1993;90:4552\u20136. https:\/\/doi.org\/10.1073\/pnas.90.10.4552.","journal-title":"Proc Natl Acad Sci USA"},{"key":"697_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12519-008-0016-8","volume":"4","author":"LQ Zhao","year":"2008","unstructured":"Zhao LQ, Han S, Tian HM. Progress in molecular-genetic studies on congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. World J Pediatr. 2008;4:85\u201390. https:\/\/doi.org\/10.1007\/s12519-008-0016-8.","journal-title":"World J Pediatr"},{"key":"697_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ng0992-66","volume":"2","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo F, et al. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet. 1992;2:66\u201374. https:\/\/doi.org\/10.1038\/ng0992-66.","journal-title":"Nat Genet"},{"key":"697_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.931389","volume":"13","author":"G Pitsava","year":"2022","unstructured":"Pitsava G, Maria AG, Faucz FR. Disorders of the adrenal cortex: genetic and molecular aspects. Front Endocrinol (Lausanne). 2022;13: 931389. https:\/\/doi.org\/10.3389\/fendo.2022.931389.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"697_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12859-022-04561-w","volume":"22","author":"YC Wu","year":"2022","unstructured":"Wu YC, Chen CI, Chen PY, Kuo CH, Hung YH, Peng KY, et al. GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1\/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism. BMC Bioinform. 2022;22:613. https:\/\/doi.org\/10.1186\/s12859-022-04561-w.","journal-title":"BMC Bioinform"},{"key":"697_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ecl.2011.01.012","volume":"40","author":"F Halperin","year":"2011","unstructured":"Halperin F, Dluhy RG. Glucocorticoid-remediable aldosteronism. Endocrinol Metab Clin N Am. 2011;40:333\u201341. https:\/\/doi.org\/10.1016\/j.ecl.2011.01.012.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"697_CR22","first-page":"3197","volume":"86","author":"S Portrat","year":"2001","unstructured":"Portrat S, Mulatero P, Curnow KM, Chaussain JL, Morel Y, Pascoe L. Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11beta-hydroxylase) and CYP11B2 (aldosterone synthase) cause steroid 11 beta-hydroxylase deficiency and congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2001;86:3197\u2013201.","journal-title":"J Clin Endocrinol Metab"},{"key":"697_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.steroids.2015.06.002","volume":"101","author":"L Xu","year":"2015","unstructured":"Xu L, Xia W, Wu X, Wang X, Zhao L, Nie M. Chimeric CYP11B2\/CYP11B1 causing 11\u03b2-hydroxylase deficiency in Chinese patients with congenital adrenal hyperplasia. Steroids. 2015;101:51\u20135. https:\/\/doi.org\/10.1016\/j.steroids.2015.06.002.","journal-title":"Steroids"},{"key":"697_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12902-018-0249-z","volume":"18","author":"L Duan","year":"2018","unstructured":"Duan L, Shen R, Song L, Liao Y, Zheng H. A novel chimeric CYP11B2\/CYP11B1 combined with a new p.L340P CYP11B1 mutation in a patient with 11OHD: case report. BMC Endocr Disord. 2018;18:23. https:\/\/doi.org\/10.1186\/s12902-018-0249-z.","journal-title":"BMC Endocr Disord"},{"key":"697_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.882863","volume":"13","author":"H Xie","year":"2022","unstructured":"Xie H, Yin H, Ye X, Liu Y, Liu N, Zhang Y, et al. Detection of small CYP11B1 deletions and one founder chimeric CYP11B2\/CYP11B1 gene in 11\u03b2-hydroxylase deficiency. Front Endocrinol (Lausanne). 2022;13: 882863. https:\/\/doi.org\/10.3389\/fendo.2022.882863.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"697_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2023.106375","volume":"233","author":"Y Xiong","year":"2023","unstructured":"Xiong Y, Zeng Z, Liang T, Yang P, Lu Q, Yang J, et al. Unequal crossing over between CYP11B2 and CYP11B1 causes 11 \u03b2-hydroxylase deficiency in a consanguineous family. J Steroid Biochem Mol Biol. 2023;233: 106375. https:\/\/doi.org\/10.1016\/j.jsbmb.2023.106375.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"697_CR27","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1210\/jcem.86.9.7820","volume":"86","author":"M Hampf","year":"2001","unstructured":"Hampf M, Dao NT, Hoan NT, Bernhardt R. Unequal crossing-over between aldosterone synthase and 11beta-hydroxylase genes causes congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2001;86:4445\u201352. https:\/\/doi.org\/10.1210\/jcem.86.9.7820.","journal-title":"J Clin Endocrinol Metab"},{"key":"697_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1399-0004.2004.00291.x","volume":"66","author":"B Ezquieta","year":"2004","unstructured":"Ezquieta B, Luzuriaga C. Neonatal salt-wasting and 11 beta-hydroxylase deficiency in a child carrying a homozygous deletion hybrid CYP11B2 (aldosterone synthase)-CYP11B1 (11 beta-hydroxylase). Clin Genet. 2004;66:229\u201335. https:\/\/doi.org\/10.1111\/j.1399-0004.2004.00291.x.","journal-title":"Clin Genet"},{"key":"697_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000087074","volume":"63","author":"I Kuribayashi","year":"2005","unstructured":"Kuribayashi I, Nomoto S, Massa G, Oostdijk W, Wit JM, Wolffenbuttel BH, et al. Steroid 11-beta-hydroxylase deficiency caused by compound heterozygosity for a novel mutation, p.G314R, in one CYP11B1 allele, and a chimeric CYP11B2\/CYP11B1 in the other allele. Horm Res. 2005;63:284\u201393. https:\/\/doi.org\/10.1159\/000087074.","journal-title":"Horm Res"},{"key":"697_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40618-015-0362-z","volume":"39","author":"S Menab\u00f2","year":"2016","unstructured":"Menab\u00f2 S, Boccassini S, Gambineri A, Balsamo A, Pasquali R, Prontera O, et al. Improving the diagnosis of 11\u03b2-hydroxylase deficiency using home-made MLPA probes: identification of a novel chimeric CYP11B2\/CYP11B1 gene in a Sicilian patient. J Endocrinol Investig. 2016;39:291\u20135. https:\/\/doi.org\/10.1007\/s40618-015-0362-z.","journal-title":"J Endocrinol Investig"},{"key":"697_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nsb0197-32","volume":"4","author":"KM Curnow","year":"1997","unstructured":"Curnow KM, Mulatero P, Emeric-Blanchouin N, Aupetit-Faisant B, Corvol P, Pascoe L. The amino acid substitutions Ser288Gly and Val320Ala convert the cortisol producing enzyme, CYP11B1, into an aldosterone producing enzyme. Nat Struct Biol. 1997;4:32\u20135. https:\/\/doi.org\/10.1038\/nsb0197-32.","journal-title":"Nat Struct Biol"},{"key":"697_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/07435809609043731","volume":"22","author":"B B\u00f6ttner","year":"1996","unstructured":"B\u00f6ttner B, Bernhardt R. Changed ratios of glucocorticoids\/mineralocorticoids caused by point mutations in the putative I-helix regions of CYP11B1 and CYP11B2. Endocr Res. 1996;22:455\u201361. https:\/\/doi.org\/10.1080\/07435809609043731.","journal-title":"Endocr Res"},{"key":"697_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1046\/j.1432-1327.1998.2520458.x","volume":"252","author":"B B\u00f6ttner","year":"1998","unstructured":"B\u00f6ttner B, Denner K, Bernhardt R. Conferring aldosterone synthesis to human CYP11B1 by replacing key amino acid residues with CYP11B2-specific ones. Eur J Biochem. 1998;252:458\u201366. https:\/\/doi.org\/10.1046\/j.1432-1327.1998.2520458.x.","journal-title":"Eur J Biochem"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-024-00697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-024-00697-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-024-00697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T02:08:50Z","timestamp":1710122930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-024-00697-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["697"],"URL":"https:\/\/doi.org\/10.1007\/s40291-024-00697-y","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"type":"print","value":"1177-1062"},{"type":"electronic","value":"1179-2000"}],"subject":[],"published":{"date-parts":[[2024,2,7]]},"assertion":[{"value":"16 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research received no external funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement (participation and publication)"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"The author (PC) declares no conflict of interest.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}